[go: up one dir, main page]

GT199800037A - Combinaciones para diabetes de sulfonilurea - glitazona. - Google Patents

Combinaciones para diabetes de sulfonilurea - glitazona.

Info

Publication number
GT199800037A
GT199800037A GT199800037A GT199800037A GT199800037A GT 199800037 A GT199800037 A GT 199800037A GT 199800037 A GT199800037 A GT 199800037A GT 199800037 A GT199800037 A GT 199800037A GT 199800037 A GT199800037 A GT 199800037A
Authority
GT
Guatemala
Prior art keywords
sulfonilurea
glitazone
diabetes
combinations
antidiabetic
Prior art date
Application number
GT199800037A
Other languages
English (en)
Inventor
Randall W Whitcomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199800037A publication Critical patent/GT199800037A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UN METODO PARA EL TRATAMIENTO DE LA DIABETES QUE CONSISTE EN ADMINISTRAR A UN SUJETO QUE REQUIERE TRATAMIENTO, UNA COMBINACION DE UN AGENTE ANTIDIABETICO DE SULFONILUREA Y UNA GLITAZONA ANTIDIABETICA. ESTOS COMPUESTOS TIENEN LAS ESTRUCTURAS BASICAS I Y II RESPECTIVAMENTE, EN LAS QUE A, B, E, Y & Z, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE.
GT199800037A 1997-02-19 1998-02-18 Combinaciones para diabetes de sulfonilurea - glitazona. GT199800037A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3822497P 1997-02-19 1997-02-19

Publications (1)

Publication Number Publication Date
GT199800037A true GT199800037A (es) 1999-08-12

Family

ID=21898725

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800037A GT199800037A (es) 1997-02-19 1998-02-18 Combinaciones para diabetes de sulfonilurea - glitazona.

Country Status (29)

Country Link
US (2) US5859037A (es)
EP (1) EP0957923A1 (es)
JP (1) JP2001512478A (es)
KR (1) KR20000071179A (es)
CN (1) CN1244801A (es)
AR (1) AR011829A1 (es)
AU (1) AU741215B2 (es)
BG (1) BG103671A (es)
BR (1) BR9714505A (es)
CA (1) CA2272478A1 (es)
CZ (1) CZ289299A3 (es)
EA (1) EA199900725A1 (es)
EE (1) EE9900345A (es)
GT (1) GT199800037A (es)
HN (1) HN1997000167A (es)
HU (1) HUP0001528A3 (es)
IL (1) IL130027A (es)
IS (1) IS5058A (es)
NO (1) NO993982D0 (es)
NZ (1) NZ336002A (es)
PA (1) PA8447401A1 (es)
PE (1) PE74399A1 (es)
PL (1) PL335166A1 (es)
SK (1) SK111899A3 (es)
SV (1) SV1998000010A (es)
TR (1) TR199902033T2 (es)
UY (1) UY24893A1 (es)
WO (1) WO1998036755A1 (es)
ZA (1) ZA981343B (es)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
US20010049380A1 (en) * 1997-06-18 2001-12-06 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and sulphonylurea
SK286028B6 (sk) * 1997-06-18 2008-01-07 Smithkline Beecham Plc Farmaceutický prostriedok a jeho použitie
DE122007000054I1 (de) * 1997-06-18 2007-12-13 Smithkline Beecham Plc Behandlung der Diabetes mit Thiazolidindione und metformin
US20020004515A1 (en) * 1997-06-18 2002-01-10 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and metformin
GB9715306D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US7105552B2 (en) * 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
AU4956699A (en) 1998-06-19 2000-01-05 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
BR9917005A (pt) * 1998-12-24 2002-04-02 Metabasis Therapeutics Inc Combinação de inibidores de fbpase e sensibilizadores de insulina para o tratamento de diabete
US7001746B1 (en) * 1999-01-29 2006-02-21 Artecel Sciences, Inc. Methods and compositions for the differentiation of human preadipocytes into adipocytes
EP1100895B1 (en) * 1999-03-15 2007-06-13 University of British Columbia Abc1 polypeptide and methods and reagents for modulating cholesterol levels
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US7563775B2 (en) * 2000-11-01 2009-07-21 Betty C. Villafuerte Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes
US20060154864A1 (en) * 1999-11-01 2006-07-13 Emory University Transcript factor and an Akt substrate related to transcriptional action of insulin and applications of same
FR2802814B1 (fr) * 1999-12-23 2002-02-22 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique de la famille des sulfonylurees
DE60103203T2 (de) 2000-04-13 2005-05-04 Pfizer Products Inc., Groton Synergistische Wirkung von Glyburide und Milrinone
GB0014969D0 (en) * 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
KR200249057Y1 (ko) * 2001-03-22 2001-10-19 김진환 뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
US6492339B1 (en) 2001-05-23 2002-12-10 Insmed, Incorporated Compositions comprising D-chiro inositol and sulfonylureas and methods of treatment thereof
SE0101982D0 (sv) * 2001-06-01 2001-06-01 Astrazeneca Ab Pharmaceutical combination
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
EP1539144B1 (en) 2002-09-20 2014-12-24 Andrx Labs Llc Multistage formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US20040147564A1 (en) * 2003-01-29 2004-07-29 Rao Vinay U. Combinations of glimepiride and the thiazolidinedione for treatment of diabetes
PL1677792T3 (pl) 2003-10-31 2016-05-31 Takeda Pharmaceuticals Co Stały preparat zawierający pioglitazon, glimepiryd i ester polioksyetylenosorbitanu z kwasem tłuszczowym
MXPA04009236A (es) * 2004-09-23 2006-03-27 Jorge Luis Rosado Loria Composicion sinergistica para el tratamiento de diabetes y sus comorbilidades.
WO2006074278A2 (en) * 2005-01-05 2006-07-13 Mitsunori Ono Compositions for treating diabetes or obesity
EP1889618A4 (en) * 2005-05-27 2010-11-24 Daiichi Sankyo Co Ltd COMBINED MEDICATION FOR THE TREATMENT OF DIABETES
US20090170762A1 (en) * 2005-09-08 2009-07-02 Uutech Limited Treatment of Diabetes Related Obesity
EP1937716A2 (en) * 2005-09-08 2008-07-02 Uutech Limited Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function
WO2007059372A2 (en) * 2005-11-09 2007-05-24 St. Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
MXPA05013220A (es) * 2005-12-06 2007-06-05 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2.
MY149306A (en) 2005-12-22 2013-08-30 Takeda Pharmaceutical Solid preparation containing an insulin sensitizer
WO2008026668A1 (fr) * 2006-08-31 2008-03-06 Daiichi Sankyo Company, Limited Composition médicale contenant un agent d'amélioration de la résistance à l'insuline
PT2068909E (pt) 2007-03-30 2012-07-04 Ambrx Inc Polipéptidos fgf-21 modificados e suas utilizações
PL2868315T3 (pl) 2007-12-04 2018-06-29 Biogen Chesapeake Llc Udoskonalone preparaty i sposoby liofilizacji oraz uzyskiwane liofilizaty
FR2928836B1 (fr) * 2008-03-21 2011-08-26 Servier Lab Forme galenique secable permettant une liberation modifiee du principe actif
RU2765463C2 (ru) 2008-12-04 2022-01-31 Чунси ЮЙ Композиции интенсивного проникновения и их применение
US20110065756A1 (en) * 2009-09-17 2011-03-17 De Taeye Bart M Methods and compositions for treatment of obesity-related diseases
BR112012011237A2 (pt) * 2009-11-13 2019-09-24 Univ Tokyo agente terapêutico e profilático para diabetes
WO2011146981A1 (en) 2010-05-24 2011-12-01 Ozstar Therapeutics Pty Ltd Anti-diabetic compositions and methods
AU2012207357B2 (en) 2011-01-19 2016-07-28 Fractyl Health, Inc. Devices and methods for the treatment of tissue
US9737559B2 (en) 2011-11-23 2017-08-22 Ozstar Therapeutics Pty Ltd Synergistic anti-diabetic compositions
CN103159651B (zh) * 2011-12-14 2015-06-17 安徽贝克联合制药有限公司 磺酰脲胍及其制备方法和用途
EP4066764A1 (en) 2012-02-27 2022-10-05 Fractyl Health, Inc. Heat ablation systems and devices for the treatment of tissue
AU2013249043B2 (en) 2012-04-19 2017-04-27 Fractyl Health, Inc. Tissue expansion devices, system and methods
EP3714826A1 (en) 2012-07-30 2020-09-30 Fractyl Laboratories, Inc. Electrical energy ablation systems and devices for the treatment of tissue
WO2014026055A1 (en) 2012-08-09 2014-02-13 Fractyl Laboratories Inc. Ablation systems, devices and methods for the treatment of tissue
WO2014055997A1 (en) 2012-10-05 2014-04-10 Fractyl Laboratories Inc. Methods, systems and devices for performing multiple treatments on a patient
WO2014197632A2 (en) 2013-06-04 2014-12-11 Fractyl Laboratories, Inc. Methods, systems and devices for reducing the luminal surface area of the gastrointestinal tract
US11986235B2 (en) 2013-09-12 2024-05-21 Fractyl Health, Inc. Systems, methods and devices for treatment of target tissue
KR102284469B1 (ko) 2013-11-22 2021-08-02 프랙틸 헬쓰, 인코포레이티드 위장관에 치료 제한부를 생성하기 위한 시스템, 장치 및 방법
US10959774B2 (en) 2014-03-24 2021-03-30 Fractyl Laboratories, Inc. Injectate delivery devices, systems and methods
US9844641B2 (en) 2014-07-16 2017-12-19 Fractyl Laboratories, Inc. Systems, devices and methods for performing medical procedures in the intestine
EP3169260B1 (en) 2014-07-16 2019-09-25 Fractyl Laboratories, Inc. System for treating diabetes and related diseases and disorders
US11185367B2 (en) 2014-07-16 2021-11-30 Fractyl Health, Inc. Methods and systems for treating diabetes and related diseases and disorders
EP3412302B1 (en) 2014-10-24 2021-05-12 Bristol-Myers Squibb Company Modified fgf-21 polypeptides and uses thereof
CN108079000A (zh) * 2018-02-01 2018-05-29 湖南博隽生物医药有限公司 一种治疗糖尿病的药物组合物及其制备方法
US20230139684A1 (en) * 2019-11-22 2023-05-04 Brown University Compositions and methods for treating, preventing or reversing age-associated inflammation and disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
HUP9601808A3 (en) * 1995-07-03 2000-06-28 Sankyo Co Treatment of arteriosclerosis and xanthoma
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
JP2001512478A (ja) 2001-08-21
EP0957923A1 (en) 1999-11-24
US5859037A (en) 1999-01-12
BR9714505A (pt) 2000-03-21
US5972973A (en) 1999-10-26
EA199900725A1 (ru) 2000-04-24
KR20000071179A (ko) 2000-11-25
NO993982L (no) 1999-08-18
UY24893A1 (es) 1998-07-10
HUP0001528A3 (en) 2000-12-28
AU741215B2 (en) 2001-11-29
BG103671A (en) 2000-04-28
ZA981343B (en) 1998-11-16
PE74399A1 (es) 1999-08-20
NZ336002A (en) 2002-03-28
AR011829A1 (es) 2000-09-13
CA2272478A1 (en) 1998-08-27
IL130027A0 (en) 2000-02-29
IL130027A (en) 2005-09-25
EE9900345A (et) 2000-02-15
SV1998000010A (es) 1999-02-02
PA8447401A1 (es) 2001-12-14
TR199902033T2 (xx) 2000-02-21
CN1244801A (zh) 2000-02-16
WO1998036755A1 (en) 1998-08-27
HUP0001528A2 (hu) 2000-11-28
PL335166A1 (en) 2000-04-10
AU5590898A (en) 1998-09-09
HN1997000167A (es) 1999-02-09
IS5058A (is) 1999-05-27
SK111899A3 (en) 2000-09-12
CZ289299A3 (cs) 1999-11-17
NO993982D0 (no) 1999-08-18

Similar Documents

Publication Publication Date Title
GT199800037A (es) Combinaciones para diabetes de sulfonilurea - glitazona.
HN1999000184A (es) Combinaciones para la diabetes
GT199800177A (es) Combinacion eficaz para el tratamiento de la impotencia .
ES2168254T3 (es) Nuevas 7-sustituidas-9-(amino sustituido)-6-desmetil-6-desoxitetraciclinas.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
ES2137372T3 (es) Solucion antifungica para las uñas.
AR013488A1 (es) COMPOSICIoN GERMICIDA ACUOSA PARA EL TRATAMIENTO O PREVENCIoN DE ENFERMEDADES INFECCIOSAS DE LAS PEZUNAS DE ANIMALES, Y USO DE DICHA COMPOSICIoN
CY1116385T1 (el) Αντινοηματικη διαμορφωση της εκφρασης της απολιποπρωτεινης β
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
ES2135083T3 (es) Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis.
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
DE69522696D1 (de) Nimesulid zur aüsserlichen anwendung
AR013479A1 (es) Metodo para aumentar el volumen oseo utilizando agonistas de prostanoide f selectivos no naturales.
ES2145062T3 (es) Ensayo mejorado de desplazamiento de cadena y complejo util para el mismo.
AR021750A1 (es) Aparato para el tratamiento topico localizado de una enfermedad
ES2190082T3 (es) Concentrados estables de vitamina c.
BR0011225A (pt) Agente para tratar de olhos secos, seu método e uso
ES2158292T3 (es) Composicion para controlar parasitos.
MX9704490A (es) Tratamiento terapeutico combinado de las patologias hiperproliferativas.
DE50101479D1 (de) Fluoresceinisothiocyanat-(fitc)-sinistrin, seine herstellung und verwendung
ES2100051T3 (es) Sintesis de bloques dimeros y su uso en el ensamblaje de oligonucleotidos.
BR9913936A (pt) Processo para prevenir ou tratar periodontite em um mamìfero, e, uso de uma composição antimicrobiana
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.